In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback